 Aridis Pharmaceuticals, Inc. Nasdaq: ARDS, a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, announced today that it will participate in a Cantor Fitzgerald hosted Virtual Fireside Chat on Thursday, June 25, 2020 at 11:00 AM ET. 